Blood Glucose Meters - Helping Diabetics Right Where They Live

Medical news

• Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma
  SAN MARINO, Calif., Nov. 20 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies announced today the results of Phase I/II and II studies of Rexin-G in chemotherapy-resistant metastatic soft tissue sarcoma and osteosarcoma, as presented by Dr. Sant P. Chawla, principal investigator, at the CTOS 14th annual meetings held in London UK on November 13-15, 2008. Patients received repeated infusions of Rexin-G i.v. over a period up to 9 months.
• Interim HealthCare Recognizes Outstanding Franchisees at National Clinical Symposium
  SUNRISE, Fla., Nov. 19 (SEND2PRESS NEWSWIRE) -- Interim HealthCare, the nation's largest provider of home care and health care staffing services, announced the recipients of the 'National Quality Awards' for 2008 at their annual National Clinical Symposium meeting in Savannah, Georgia. The awards recognize Interim home care offices for patient satisfaction, and Medicare-certified offices for performance on CMS public measures of quality.
• Cognitive Technologies Supports PMO for APS Healthcare
  AUSTIN, Texas, Nov. 19 (SEND2PRESS NEWSWIRE) -- Cognitive Technologies, an IT consulting company specializing in project and program management for the Federal Government and Fortune 1000 companies, is pleased to announce that they have been engaged by APS Healthcare to sustain and improve their Project Management Office (PMO). Cognitive Technologies initially will be assisting with the management of the PMO for the Corporate IT department.
• USPTO Issues a Notice of Allowance for MMDI's BetaWire(TM) Guidewire Patent
  MINNEAPOLIS, Minn., Nov. 19 (SEND2PRESS NEWSWIRE) -- Minnesota Medical Development, Inc. (MMDI) today announced that the United States Patent and Trademark Office has issued a Notice of Allowance for the company's BetaWire(TM) guidewire technology. The BetaWire(TM) is a super-torque interventional guidewire manufactured from a Beta Titanium alloy. Guidewires are thin, flexible wires that are used to facilitate the placement of balloon catheters and other diagnostic and therapeutic devices.
• Shortness of Breath? Stronger Lungs for Better Breathing (100-percent Drug Free)
  MIAMI, Fla., Nov. 18 (SEND2PRESS NEWSWIRE) -- The Expand-A-Lung(TM) Breathing Resistance Exerciser from Expand-A-Lung, Inc. was selected the #1 choice of the L.A. Times for breathing fitness training. Jorge Brouwer, inventor of the most compact (4-inches) breathing exerciser, manufactures and markets the easy to use Expand-A-Lung.
• Eularis Analyzes Pre-Launch Brand Planning with New Pharmaceutical Industry Report
  NEW YORK, LONDON, TOKYO, Nov. 17 (SEND2PRESS NEWSWIRE) -- In today's environment, Pharmaceutical companies find themselves in a bind. Drug launches used to be able to achieve high sales and profits - until recently. Every Pharma company today is hoping to achieve their own immediate winners, the drugs that are successful right from the start and provide years of business-sustaining profit. However, recent studies have shown that seven out of ten drugs launched in the last five years have failed to repay their R&D investment.
• Biometric Technologies Inc. Selects SecuGen's Hamster(TM) IV Fingerprint Reader to Reduce Phantom Billing
  SANTA CLARA, Calif., Nov. 3 (SEND2PRESS NEWSWIRE) -- SecuGen Corporation is pleased to announce that Biometric Technologies, Inc. has integrated the SecuGen Hamster(TM) IV into BIOCLAIM(R), their flagship software product. BIOCLAIM is the only medical billing solution that provides biometric confirmation that a patient was actually present to receive healthcare services.
• ACE Vision Group, Inc. Announces New Global Medical Director, Dr. Marguerite McDonald
  SILVER LAKE, Ohio, Oct. 30 (SEND2PRESS NEWSWIRE) -- ACE Vision Group, Inc. today announced the appointment of Marguerite McDonald, M.D. as Global Medical Director. Dr. McDonald is a cornea / refractive / anterior segment specialist for Ophthalmic Consultants of Long Island, Lynbrook, NY. She is presently a Clinical Professor of Ophthalmology at New York University (NYU) in Manhattan and an Adjunct Clinical Professor of Ophthalmology at Tulane University School of Medicine in New Orleans.
• Rexin-G Returns to The Big Apple: Clinical Trials for Pancreatic Cancer and Breast Cancer Open in Manhattan
  SAN MARINO, Calif., Oct. 29 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation announced today the expansion of clinical trials using intravenous Rexin-G for pancreatic cancer and breast cancer in Manhattan, New York. Rexin-G is the world's first tumor-targeted genetic medicine that is designed to seek out and destroy both primary tumors and metastatic cancers that have spread throughout the body.
• SELECT TRIAL used Selenomethionine Instead of High-Selenium Yeast, SelenoExcell(R)
  FRESNO, Calif., Oct. 29 (SEND2PRESS NEWSWIRE) -- Cypress Systems, Inc, a Fresno CA based biotechnology company, emphasizes that the SELECT TRIAL results - that were announced yesterday - used a form of selenium known as selenomethionine. The SELECT TRIAL found no effects of either selenomethionine or vitamin E on the incidence of prostate cancer. See Related Website at cypsystems.com.